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Plasma and muscle free amino acids in maintenance hemodialysis
patients without protein malnutrition. To investigate how uremia mod-
ified by maintenance hemodialysis treatment influences the extra- and
intracellular amino acid pattern, we collected muscle samples by
percutaneous muscle biopsy and plasma samples for determination of
free amino acids in 11 functionally anephric patients (creatinine clear-
ance <I mi/mm), who had been treated with hemodialysis for >6
months and had no clinical or laboratory signs of protein malnutrition.
Five patients had mild acidosis (standard bicarbonate pre-dialysis 18 to
21 mmol/liter). The amino acid results were compared with data from
age- and sex-matched healthy controls and with data obtained earlier
from non-dialyzed patients with chronic uremia. In the hemodialysis
patients threonine, serine and valine were significantly reduced in
plasma compared to the controls, whereas the plasma concentrations of
aspartate, glycine, citrulline, cysteine and arginine were elevated. In
muscle, valine, serine and the tyrosine to phenylalanine ratio were low.
Compared with the untreated uremic patients the hemodialysis patients
exhibited fewer significant abnormalities, but the general pattern was
similar, demonstrating that hemodialysis is unable to fully correct the
amino acid abnormalities of chronic uremia. There was a significant
positive correlation between both pre-dialysis and post-dialysis plasma
bicarbonate and the muscle valine concentration, suggesting that mild
acidosis may be causally related to the inbalance of the branched-chain
amino acids in uremia. Extra- and intracellular serine depletion in the
presence of high plasma glycine may reflect a defect in the metabolism
of glycine to serine in hemodialysis patients, related to a lack of
metabolizing renal tissue.
In patients with chronic renal failure treated with mainte-
nance hemodialysis most clinical symptoms of uremia diminish
or disappear. However, several features of uremia are still
present, such as alterations in intermediary metabolism, de-
pressed immunological functions, endocrine abnormalities and
elevated plasma concentrations of urea, creatinine and other
metabolic end products, demonstrating that hemodialysis is
unable to fully compensate for loss of the kidneys' excretory
and metabolic functions. A common problem in maintenance
hemodialysis patients (HD patients) is protein malnutrition
[1—101, which is an important factor for morbidity and mortality
in such patients [8—10]. The dialytic procedure per se seems to
be a strong stimulus for protein catabolism [11], which contrib-
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utes to increasing the minimum protein requirements of chronic
hemodialysis patients compared to healthy individuals and
non-dialyzed patients with chronic uremia.
Many studies document the presence of abnormalities in
amino acid metabolism in chronic uremia [12]. These abnormal-
ities have been attributed to low protein intake, deficiency of
excretory and metabolic functions of the diseased kidneys,
toxic effects of uremia on the intermediary metabolism of amino
acids and, in dialysis patients, loss of protein and amino acids
by the dialytic procedure.
The concentration of several essential amino acids in plasma
has been found to be low in non-dialyzed patients with chronic
renal failure and in patients treated with maintenance hemodi-
alysis or peritoneal dialysis, while the concentration of some
non-essential amino acids have been reported to be abnormally
high [13—19].
In chronic uremia the distribution of some amino acids
between the extra- and intracellular compartments is altered
[16, 17, 19]. By far the largest pool of free amino acids is within
the skeletal musculature [201, which in an adult man represents
about 40% of the body weight. For most amino acids the muscle
intracellular concentration is higher than the plasma concentra-
tion [20]. Amino acid determination in muscle rather than a
plasma aminogram may therefore provide more accurate infor-
mation about the total pool of each free amino acid.
In untreated patients with chronic renal failure the intracel-
lular free amino acid profile in muscle exhibits several abnor-
malities, some of which may be influenced by the nutritional
intake of protein and amino acids [16, 17, 21]. Intracellular
amino acid abnormalities have also been observed in chronic
uremic patients treated with intermittent peritoneal dialysis [16]
and continuous ambulatory peritoneal dialysis [19].
In this communication we report plasma and muscle concen-
trations of free amino acids in patients with chronic uremia
treated with maintenance hemodialysis. The patients selected
for this study had an estimated protein intake considered to be
adequate for hemodialysis patients and had no clinical or
laboratory evidence of protein malnutrition. Thus, any amino
acid abnormalities observed should reflect the influence of the
anephric state and its sequele plus effects of the dialysis
procedure on amino acid metabolism, rather than being unspe-
cific signs of protein depletion. Some of these data were earlier
presented in a preliminary form [22].
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Table 1. Serum biochemistries in the hemodialysis patients
Total
protein
.Albumin Transferrin
mg/liter
Urea
mmol/liter
Creatinine
Mmol/liter
Standard
bicarbonate
mmol/literglliter
Before dialysis
After dialysis
Normal range
73.7 5.0
—
65—85
44.5 4.6
—
37—52
2.94 0,82
—
2.1—3.6
32.1 5.0
15.5 3.4
<9
1179 232
639 140
<110
21.6 2.2
24.7 1.6
22—26
Data are presented as means standard deviation.
Methods
Eleven patients with chronic renal failure, seven males with a
mean age of 41 (19 to 56) years and four women with a mean age
of 45 (26 to 56) years were studied. They had been treated with
intermittent hemodialysis for an average time of 36 (6 to 84)
months. None of the patients had diabetes mellitus or other
systemic diseases. All patients had a creatinine clearance less
than 1 mI/mm. They had no evidence of chronic infection, no
signs of muscle wasting and fatigue and no weight loss over the
six month period preceeding the time of the investigation.
Hemodialysis was performed three times per week using dia-
lyzers with cellulose membranes and acetate as the buffer anion
in the dialysis fluid. The patients were treated with diuretics,
antihypertensive drugs, calcium carbonate and aluminium hy-
droxide as required. Severe acidosis was prevented by oral
medication with sodium bicarbonate tablets. None of the pa-
tients received corticosteroids or androgenic steroid therapy.
All patients were prescribed a daily supplement of water-
soluble vitamins (the B vitamins and ascorbic acid).
Their percentage ideal body weight (post-dialysis) based
upon medium framed individuals [23] was 104 15 (mean
SD). In one male patient the percent of ideal body weight (80%)
was clearly below the recommended level but the patient had no
other signs of wasting or malnutrition. The daily protein intake,
estimated from monthly determinations of the urea appearance
rate by using a pharmacokinetic model [24] was 1.07 0.15 glkg
body weight/day; it was higher than 0.9 glkglday in 10 of the
patients and 0.87 in one patient. Dietary recall records (based
on 2 or 3 days) in seven patients showed on average slightly
higher protein intakes (1.23 0.13 g/kglday; mean SD) than in
the same patients calculated from the urea appearance rate
(1.09 0.06 g/kglday), but the difference was not significant.
The energy intake estimated from the dietary recall records in
these patients was 37 9 kcal/kg/day.
The concentration of several free amino acids in plasma and
muscle varies with age and sex [25—27]. The control group of 11
healthy volunteers, seven males with a mean age of4l (20 to 54)
years and four women with a mean age of 46 (28 to 57) years,
was therefore selected to be similar to the clinical group with
regard to age and sex distribution. The percent ideal body
weight in the controls (106 8) was not significantly different
from that in the hemodialysis patients.
Serum biochemistries are presented in Table 1. All patients
had a normal serum total protein, albumin and transferrin
concentration. Pre- and postdialysis data are given for urea,
creatinine and standard bicarbonate by averaging values ob-
tained monthly before and after the first dialysis of the week
over a period of two to three months. Reliable standard
bicarbonate values were available in only 10 patients. Five of
the patients were slightly acidotic with standard bicarbonate
21.0 mmoL/liter before dialysis; after dialysis the standard
bicarbonate was 24 to 27 mmol/liter in eight patients and 22 and
22.5 mmollliter respectively, in two patients.
The plasma and muscle amino acid concentrations in the
hemodialysis patients as percent of the concentrations in the
controls were compared with corresponding data in 12 non-
dialyzed patients (6 men and 6 women) with advanced chronic
renal failure published earlier [16]. These patients had a mean
serum creatinine 1015 336 molIliter and urea 32.4 5.5
mmollliter (mean SD).
Muscle biopsy and analytical methods
Sampling of muscle for amino acid determination was made
in the morning after an overnight fast on a mid-week, dialysis-
free day. Muscle tissue was obtained from the quadriceps
femoris by percutaneous needle biopsy [28]. Venous blood for
determination of plasma amino acids and routine blood chem-
istry were obtained at the time of the muscle biopsy.
The muscle biopsy material (about 40 to 80 mg) was rapidly
dissected free from all visible fat and connective tissue and then
divided into several portions, which were weighed on a Cahn
electrobalance. One to three pieces (10 to 20 mg each) were
used for determinations of fat, water and chloride as described
earlier [28—30]. Two larger pieces (20 to 40 mg) were used for
duplicate determinations of muscle free amino acids. Muscle
and plasma samples were deproteinized with sulphosalicylic
acid, centrifuged and the supernatants stored at —70°C until
analyzed. Free amino acids were determined by ion exchange
chromatography using an automatic amino acid analyzer (La-
botron CHR-2 or Liquimat III, Kontron, Switzerland, or amino
acid analyzer 4400 or 4151 Alpha Plus, LKB Biochrom Ltd,
Cambridge, UK) using a lithium buffer system with five pi-
cobuffers and an internal standard (norleucine) [20]. The calcu-
lations of extra- and intracellular water and the intracellular
amino acid concentrations in muscle based on the chloride
method have been described earlier [20, 29, 30].
Statistics
The tests of significance for the difference between the means
of two independent samples were made by the Student's f-test
when the population variances were the same. When variances
were different the comparison between the two means were
made using the Behrens-Fisher test with Cochran's modifica-
tion. The test of the equality of the variances was made by use
of the F-test with a 5% level of significance (two-tailed).
The study protocol was approved by the local Ethics Comit-
tees of the Karolinska Institute at St Erik's Hospital and
Huddinge University Hospital in Stockholm.
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Table 2. Plasma free amino acid and muscle intracellular free amino acid concentrations in maintenance hemodialysis (HD) and control
subjects
Plasma-free amino acids molI1iter plasma water Muscle-free amino acids smol/liter intracellular water
N Controls N HD N Controls N HD
Essential
Histidine (11) 0.115 0.007 (11) 0.098 0.009 (11) 0.687 0.093 (II) 0.530 0.077
Isoleucine (11) 0.069 0.006 (11) 0.058 0.005 (11) 0.116 0.014 (II) 0.097 0.013
Leucine (11) 0.154 0.012 (11) 0.122 0.011 (9) 0.214 0.025 (11) 0.206 0.037
Lysine (11) 0.225 0.015 (10) 0.193 0.012 (11) 1.44 0.16 (11) 1.24 0.11
Methionine (11) 0.029 0.002 (11) 0.036 0,003 (10) 0.043 0.006 (11) 0.050 0.009
Phenylalanine (11) 0.066 0.005 (11) 0.077 0.006 (11) 0.098 0.012 (11) 0.121 0.012
Threonine (11) 0.191 0.015 (11) 0.142 0.009a (11) 1.05 0.08 (11) 0.95 0.17
Tyrosine (11) 0.085 0.006 (11) 0.073 0.011 (11) 0.175 0.033 (11) 0.132 0.025
Valine (11) 0.284 0.023 (11) 0.203 0.0l4' (11) 0.341 0.027 (11) 0.233 0.019"
Tyr/Phe (11) 1.28 0.04 (11) 1.10 0.17 (11) 1.69 0.19 (11) 1.03 0.02a
Non-essential
Alanine (11) 0.423 0.024 (11) 0.482 0.043 (11) 3.83 0.22 (11) 3.43 0.31
Arginine (11) 0.082 0.006 (11) 0.115 o.oloa (11) 1.21 0.28 (11) 0.83 0.08
Asparagine (11) 0.059 0.005 (10) 0.067 0.006 (11) 0.414 0.041 (10) 0.318 0.056
Aspartate (11) 0.012 0.002 (11) 0.029 0.005a (11) 2.21 0.22 (11) 2.62 0.20
Citrulline (II) 0.045 0.005 (11) 0.131 0.007c (9) 0.243 0.074 (10) 0.204 0.058
Cysteine (11) 0.065 0.005 (11) 0.115 0,006c
Glutamate (9) 0.045 0.007 (11) 0.042 0.009 (11) 4.80 0.39 (11) 4.10 0.34
Glutamine (11) 0.743 0.045 (11) 0.979 0.246 (11) 23.7 2.3 (10) 19.7 1.7
Glycine (11) 0.293 0.017 (11) 0.481 0.033c (11) 2.25 0.21 (11) 2.28 0.33
Ornithine (10) 0.113 0.015 (11) 0.094 0.007 (11) 0.463 0.037 (11) 0.441 0.060
Proline (10) 0.257 0.036 (11) 0.349 0.052 (11) 1.35 0.20 (11) 1.44 0.21
Serine (10) 0.157 0.013 (11) 0.108 0.008" (11) 1.25 0.07 (11) 0.90 0.14a
Values are given as means SE. Histidine and tyrosine are regarded as essential amino acids in uremia.
ap< 0.05
bP < 0.01C< 0.001
Results
Plasma amino acids
The concentrations of threonine, valine and serine were
significantly reduced compared to the controls (Table 2). The
concentrations of aspartate, glycine, citrulline, cysteine and
arginine were elevated.
Muscle free amino acids
The concentrations of valine and serine were significantly
decreased compared to the controls (Table 2).
Concentration gradient
The intracellular/extracellular concentration gradient was sig-
nificantly decreased in the hemodialysis patients for glycine
(mean sE; patients 4.71 0.55, controls 7.62 0.51; P <
0.002), citrulline (1.73 0.56 vs. 5.14 1.26; P < 0.05) and
arginine (7.14 1.13 vs. 14.75 3.18; P < 0.05).
The tyrosine/phenylalanine ratio was significantly reduced in
muscle (P < 0.05).
Relationship between acidosis and concentration of
branched-chain amino acids in plasma and muscle
Since acidosis has been shown to affect the metabolism of the
branched-chain amino acids in normal and uremic rats [31], we
sought correlations between the concentrations of these amino
acids in plasma and muscle against standard bicarbonate in
plasma. We found that the muscle concentration of valine was
significantly correlated to standard bicarbonate pre-dialysis (r
0.81, P <0.01; Fig. 1) and post-dialysis (r = 0.74, P <0.05), but
no such correlations were found for plasma valine, leucine or
isoleucine in plasma or muscle.
Comparison with data from patients with untreated chronic
uremia
The untreated patients had significantly reduced plasma
concentrations of all essential amino acids except histidine,
isoleucine and methionine (Figs. 2 and 3). The hemodialysis
patients exhibited fewer abnormalities, only valine and threo-
nine being significantly reduced, but the general pattern was
similar. Of the non-essential amino acids in plasma, serine and
ornithine were low in the non-dialyzed patients and aspartate
and citrulline were high; the pattern in the dialysis patients was
similar except that ornithine was normal and glycine and
arginine elevated. Also in muscle the amino acid pattern was
less disturbed in the hemodialysis patients who had normalized
intracellular concentrations of threonine and lysine and arginine
compared to the untreated patients. However, intracellular
valine depletion in the presence of normal leucine and isoleu-
cine was still seen in the hemodialysis patients who, in contrast
to the non-dialyzed patients, also exhibited significantly low
intracellular serine levels.
Discussion
The hemodialysis patients in this study were all in good
general condition, with stable body weight and no clinical or
laboratory signs of protein malnutrition. Based on data from the
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26 Fig. 1. Relationship between pre-dialysisstandard bicarbonate and muscle valine
concentration in JO hemodialysis patients.
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Fig. 2. Plasma and muscle essential amino acid concentrations in 12
untreated patients (U) with chronic renal failure (from ref. 17) and in
the 11 hemodialysis patients () of the present investigation. The data
(mean SE) are given as percentage of the normal concentrations in
age- and sex-matched control groups.
National Cooperative Dialysis Study in the United States [32],
it has been suggested that a "safe" intake of protein in patients
on intermittent hemodialysis should be higher than 0.8 g/kg
body wt/day. Hence, evaluated from the urea appearance rate
and from dietary recall data our patients probably had an
adequate protein intake.
Compared to patients with untreated chronic uremia (Figs. 2
and 3) the hemodialysis patients had as a whole less abnormal
free amino acid concentrations in plasma and muscle, although
the general pattern tended to be similar. Plasma leucine, lysine
phenylalanine and muscle threonine, lysine and arginine were
all low in the untreated patients, but not significantly decreased
in the hemodialysis patients. This may presumably be a conse-
quence of higher protein intake and better nutritional status in
the hemodialysis patients than in the non-dialyzed patients in
whom anorexia might have adversely affected the intake of
nutrients. However, some of the amino acid abnormalities
typical of untreated chronic uremia were still present in the
hemodialysis patients. These amino acid abnormalities were
conceivably not caused by a low protein intake or by clinical
protein malnutrition but a consequence of the functionally
anephric state and/or its treatment. It has recently been re-
ported [331 that rats with mild renal failure exhibit several
amino acid abnormalities similar to those in the present study,
even though food intake and weight gain in the azotemic rats
was the same as in controls. This suggests that azotemia per se
and not malnutrition was the cause of many of the amino acid
abnormalities.
The dialysis procedure per se seems to be a catabolic
stimulus that could contribute to the increased protein require-
ments of hemodialysis patients compared to normal individuals.
Borah et al [11] found that nitrogen balance was strongly
negative on the dialysis days, while on non-dialysis days the
balance was less negative when the protein intake was low (0.5
glkg body wt/day) and positive with a higher protein intake (1.2
glkg/day). Loss of amino acids in the dialysate probably plays
only a minor role, since the mean loss of free plus conjugated
amino acids per dialysis is no more than about 10 to 12 g, that
400
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Fig. 3. Plasma and muscle non-essential amino acid concentrations in
12 untreated patients ) with chronic renal failure (from ref. 17) and in
the 11 hemodialysis patients () of the present investigation. The data
(mean SE) are given as percentage of the normal concentrations in
age- and sex-matched control groups.
is, on average about 5 g per day over one week [34]. In normal
individuals subject to 150 minutes of sham-dialysis, a procedure
by which blood is passed through a dialyzer without circulating
dialysate, the interaction between blood and the dialyzer mem-
branes elicited an increased net efflux of amino acids from the
leg musculature corresponding to catabolism of about 20 g
protein in the whole body [35, 36]. This effect could possibly be
mediated by macrophages, stimulated by the blood-membrane
contact to release interleukin-1 [37] and cachectin [38]. This in
turn may act synergistically to induce catabolism in skeletal
muscle [39]. In clinical hemodialysis, endotoxin fragments
passing through the dialysis membranes [40], acetate in the
dialysis fluid [41] and greater monocyte activation from more
prolonged blood-membrane contact may additionally stimulate
monokine release and enhance protein catabolism even more.
It is, however, unlikely that loss of amino acids and inflam-
matory stimulation of protein catabolism induced by the hemo-
dialysis procedure might induce those amino acid abnormalities
in plasma and muscle that are common for non-dialyzed and
dialysis patients with chronic renal failure. More likely, meta-
bolic effects of substances retained in renal failure and the loss
of kidney metabolic functions might be factors responsible for
these alterations.
The hemodialysis patients had extra- and intracellular valine
depletion in presence of normal intracellular concentrations of
leucine and isoleucine, that is, a similar branched-chain amino
acid pattern as in the untreated patients with chronic renal
failure (Figs. 2 and 3). We have reported earlier that treatment
of chronic uremic patients with a low protein diet supplemented
with two to three times minimum requirements of essential
amino acids in the proportions recommended by Rose [42] fails
to correct this abnormality, whereas supplementation with a
modified amino acid mixture containing a higher proportion of
valine (more valine than leucine) normalized the plasma and
muscle valine concentration and improved nitrogen utilization
[16, 43]. These observations indicate that the metabolic break-
down of valine in relation to the other two branched-chain
amino acids is increased in chronic uremia, leading to an amino
acid imbalance with selective valine deficiency, which can be
overcome by providing an excess of valine.
The cause of the branched-chain amino acid abnormalities in
chronic uremia is far from clear. These amino acids are mainly
metabolized in muscle by deamination to their keto-analogues.
This is followed by oxidation, mediated through a common
branched-chain ketoacid dehydrogenase complex, which is
rate-limiting for branched-chain amino acid degradation [44]. It
has recently been reported that in normal and uremic rats
acidosis appears to enhance protein degradation in muscle [45,
46], and that this effect could be attributed to stimulation of
branched-chain amino acid decarboxylation, thereby bringing
about depletion of the branched-chain amino acids [31]. The
amino acid most affected was valine. Since branched-chain keto
acid decarboxylation was not stimulated when muscles were
incubated in acidified media, it appears that the acidosis must
be chronic to cause a change in branched-chain keto acid
decarboxylation [47]. When acidosis was prevented by giving
sodium bicarbonate the decarboxylation of branched-chain
amino acids and the increase in protein catabolism were abol-
ished, indicating that acidosis and not uremia was the catabolic
stimulus.
We observed a significant correlation between the predialysis
standard bicarbonate concentration and the valine concentra-
tion in muscle (Fig. 1), but not with the concentration of valine
in plasma. Similarly, there was no correlation with the concen-
trations of leucine or isoleucine in plasma or muscle. These
findings suggest that acidosis is an important factor for the
imbalance of the branched-chain amino acids in uremia with
selective valine depletion. Acidosis may presumably influence
the branched-chain amino acid metabolism not only by stimu-
lating branched-chain amino acid decarboxylation [31], but also
by modulating the metabolic activity towards preferential deg-
radation of valine. It should be emphasized that although the
degree of acidosis was mild and intermittent, it appeared to
have a marked influence on the intracellular valine pooi in
muscle. Whether uremia independently of acidosis additionally
influences branched-chain amino acid metabolism cannot be
evaluated from our data. It is conceivable that under conditions
of low protein intake or increased catabolic stress, valine
depletion might be a limiting factor for protein synthesis in
maintenance hemodialysis patients. Full correction of acidosis
to normal plasma bicarbonate levels before dialysis is therefore
an obvious goal of therapy to prevent selective degradation of
valine. It has been reported that correction of metabolic acido-
sis improves nitrogen balance in non-dialyzed chronic uremic
patients [48]. One may speculate whether this effect is mediated
by a correction of the branched-chain amino acid imbalance.
The normal kidney converts glycine to serine and is a major
endogenous source of serine [49]. Studies of the turnover of
serine in normal and diseased kidneys in the dog and in man [50,
51] suggest that the low serine and high glycine plasma levels in
0
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uremic patients result from decreased production by the kid-
neys. Our observation that the HD patients had low serine
concentrations both in plasma and muscle indicates that they
were more severely serine-depleted than the non-dialyzed
chronic renal failure patients, in whom muscle serine was
normal. One explanation may be that the maintenance dialysis
patients had less metabolizing renal tissue left than the non-
dialyzed patients, and thus a more profound deficiency in the
renal synthesis of serine from glycine. This conclusion is
corroborated by our observation that plasma glycine was also
markedly increased in the HD patients while not being elevated
in the non-dialyzed patients. Our findings suggest that serine
may be indispensible for uremic patients on maintenance he-
modialysis and that serine depletion may be another limiting
factor for protein synthesis, thereby contributing to the in-
creased protein requirements in these patients. It should be
pointed out that serine is the only non-essential amino acid
which has been shown to stimulate protein synthesis in vitro
[52].
A high tyrosine/phenylalanine ratio (in this material attaining
statistical significance in muscle but not in plasma) has been
described earlier in the plasma of patients with chronic renal
failure [12] and in the muscle of non-dialyzed patients [16, 17],
and is attributed to reduced synthesis of tyrosine from phenyl-
alanine [53, 54] due to inhibition of phenylalanine hydroxylase
[53]. Turn-over studies indicate that the conversion of phenyl-
alanine to tyrosine to a large extent takes place in the kidneys
[51, 52], which might at least partly explain why the ratio is low
in renal failure patients, for whom tyrosine may be an indispen-
sible amino acid. Intracellular tyrosine depletion was observed
in patients treated with low protein diet [16] and in CAPD
patients [19]. In the hemodialysis patients the muscle concen-
tration of tyrosine was borderline low compared to the controls
(P < 0.1), suggesting that the requirements for this amino acid
was not completely fulfilled.
The kidney takes up citrulline and produces arginine both in
rat [55] and in man [54]. It has been suggested that low renal
extraction could account for elevated plasma concentrations of
citrulline possibly related to low arginine synthetase in the
diseased kidneys [55, 56]. As a consequence, arginine may also
be indispensible for patients with chronic uremia. In the main-
tenance hemodialysis patients high plasma citrulline was not
associated with low arginine in plasma and muscle; on the
contrary the plasma arginine concentration was elevated. Thus,
supplementation with arginine seems not to be necessary in
such patients provided that the protein intake is adequate.
Markedly elevated cysteine (1/2-cystine) levels in plasma of
the same order as in the non-dialyzed patients were found in the
hemodialyzed patients. Such patients also show evidence of
taurine depletion with low muscle taurine concentrations [57],
suggesting that the metabolism of cysteine to taurine is inhibited
in uremia. Recent observations that the concentration of cys-
teinsulfinic acid is high in non-dialyzed and dialyzed patients
with chronic renal failure suggests that cysteinsufinic acid
decarboxylase, a rate-limiting enzyme in the transsulfuration
pathway, is inhibited in chronic uremia [58].
In conclusion some of the amino acid abnormalities observed
earlier in untreated chronic uremic patients are attenuated or
disappear completely in maintenance dialysis patients provided
that they are adequately dialyzed and the protein intake is
sufficient. Valine depletion is still present in the hemodialysis
patients, the degree correlating with the degree of metabolic
acidosis. Serine depletion appears to be more marked than in
untreated uremia. These persisting amino acid abnormalities
may well act in conjunction with the catabolic stress Of the
hemodialysis treatment to increase the minimum protein re-
quirements and enhance the risk of protein malnutrition. To
correct the amino acid abnormalities and improve nitrogen
utilization in hemodialysis patients, correction of acidosis and
supplementation of the diet with serine should be considered.
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